These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 18927318)

  • 1. Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells.
    Peterfalvi A; Gomori E; Magyarlaki T; Pal J; Banati M; Javorhazy A; Szekeres-Bartho J; Szereday L; Illes Z
    Int Immunol; 2008 Dec; 20(12):1517-25. PubMed ID: 18927318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis.
    Miyazaki Y; Miyake S; Chiba A; Lantz O; Yamamura T
    Int Immunol; 2011 Sep; 23(9):529-35. PubMed ID: 21712423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered production of immunoregulatory cytokines by invariant Valpha19 TCR-bearing cells dependent on the duration and intensity of TCR engagement.
    Shimamura M; Huang YY; Kobayashi M; Goji H
    Int Immunol; 2009 Feb; 21(2):179-85. PubMed ID: 19106232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jα33+ MAIT cells play a protective role in TNBS induced intestinal inflammation.
    Ruijing X; Mengjun W; Xiaoling Z; Shu P; Mei W; Yingcheng Z; Yuling H; Jinquan T
    Hepatogastroenterology; 2012 May; 59(115):762-7. PubMed ID: 22115767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus.
    Cho YN; Kee SJ; Kim TJ; Jin HM; Kim MJ; Jung HJ; Park KJ; Lee SJ; Lee SS; Kwon YS; Kee HJ; Kim N; Park YW
    J Immunol; 2014 Oct; 193(8):3891-901. PubMed ID: 25225673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells.
    Tang XZ; Jo J; Tan AT; Sandalova E; Chia A; Tan KC; Lee KH; Gehring AJ; De Libero G; Bertoletti A
    J Immunol; 2013 Apr; 190(7):3142-52. PubMed ID: 23447689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults.
    Lee OJ; Cho YN; Kee SJ; Kim MJ; Jin HM; Lee SJ; Park KJ; Kim TJ; Lee SS; Kwon YS; Kim N; Shin MG; Shin JH; Suh SP; Ryang DW; Park YW
    Exp Gerontol; 2014 Jan; 49():47-54. PubMed ID: 24269212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
    Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of immunological disorders by invariant Vα19-Jα33 TCR-bearing cells.
    Shimamura M; Huang YY; Goji H; Endo S; Migishima R; Yokoyama M
    Immunobiology; 2011 Mar; 216(3):374-8. PubMed ID: 20832138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolipids with nonreducing end alpha-mannosyl residues that have the potential to activate invariant Valpha19 NKT cells.
    Shimamura M; Huang YY; Okamoto N; Watanabe Y; Murakami Y; Kinoshita T; Hirabayashi Y; Murakata C; Ito Y; Ogawa T
    FEBS J; 2007 Jun; 274(11):2921-32. PubMed ID: 17488284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.
    Lynch L; O'Shea D; Winter DC; Geoghegan J; Doherty DG; O'Farrelly C
    Eur J Immunol; 2009 Jul; 39(7):1893-901. PubMed ID: 19585513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.
    Peralbo E; Alonso C; Solana R
    Exp Gerontol; 2007 Aug; 42(8):703-8. PubMed ID: 17604928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of NK1.1(+) invariant Valpha19 TCR(+) cells in the liver with potential to promptly respond to TCR stimulation.
    Shimamura M; Huang YY; Migishima R; Yokoyama M; Saitoh T; Yamamura T
    Immunol Lett; 2008 Nov; 121(1):38-44. PubMed ID: 18789972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKT and MAIT invariant TCRα sequences can be produced efficiently by VJ gene recombination.
    Greenaway HY; Ng B; Price DA; Douek DC; Davenport MP; Venturi V
    Immunobiology; 2013 Feb; 218(2):213-24. PubMed ID: 22647874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma.
    Waziri A; Killory B; Ogden AT; Canoll P; Anderson RC; Kent SC; Anderson DE; Bruce JN
    J Immunol; 2008 Jun; 180(11):7673-80. PubMed ID: 18490770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention.
    Prinz PU; Mendler AN; Masouris I; Durner L; Oberneder R; Noessner E
    J Immunol; 2012 Jun; 188(12):5990-6000. PubMed ID: 22573804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
    Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
    Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
    Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
    van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
    Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.